These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33576249)

  • 41. Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
    Bramante CT; Buse J; Tamaritz L; Palacio A; Cohen K; Vojta D; Liebovitz D; Mitchell N; Nicklas J; Lingvay I; Clark JM; Aronne LJ; Anderson E; Usher M; Demmer R; Melton GB; Ingraham N; Tignanelli CJ
    J Med Virol; 2021 Jul; 93(7):4273-4279. PubMed ID: 33580540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
    Teo YH; Teo YN; Syn NL; Kow CS; Yoong CSY; Tan BYQ; Yeo TC; Lee CH; Lin W; Sia CH
    J Am Heart Assoc; 2021 Feb; 10(5):e019463. PubMed ID: 33625242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus.
    Labenz C; Kostev K; Alqahtani SA; Galle PR; Schattenberg JM
    Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):172-177. PubMed ID: 33601426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.
    Deehan EC; Colin-Ramirez E; Triador L; Madsen KL; Prado CM; Field CJ; Ball GDC; Tan Q; Orsso C; Dinu I; Pakseresht M; Rubin D; Sharma AM; Tun H; Walter J; Newgard CB; Freemark M; Wine E; Haqq AM
    Trials; 2021 Feb; 22(1):148. PubMed ID: 33596993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure-There Is No Time for Delay.
    Fonarow GC; Yancy CW
    JAMA Cardiol; 2021 May; 6(5):507-508. PubMed ID: 33595602
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial.
    Yoneda M; Honda Y; Ogawa Y; Kessoku T; Kobayashi T; Imajo K; Ozaki A; Nogami A; Taguri M; Yamanaka T; Kirikoshi H; Iwasaki T; Kurihashi T; Saito S; Nakajima A
    BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33593749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Metformin on Cardiac Metabolism and Longevity in Aged Female Mice.
    Zhu X; Shen W; Liu Z; Sheng S; Xiong W; He R; Zhang X; Ma L; Ju Z
    Front Cell Dev Biol; 2020; 8():626011. PubMed ID: 33585467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis.
    Jiang Y; Liu J; Chen X; Yang W; Jia W; Wu J
    Adv Ther; 2021 Mar; 38(3):1470-1482. PubMed ID: 33582976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor.
    Shimizu K; Fujikura H; Fushimi N; Nishimura T; Tatani K; Katsuno K; Fujimori Y; Watanabe S; Hiratochi M; Nakabayashi T; Kamada N; Arakawa K; Hikawa H; Azumaya I; Isaji M
    Bioorg Med Chem; 2021 Mar; 34():116033. PubMed ID: 33581390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells.
    Kim D; Kim Y; Lee BB; Cho EY; Han J; Shim YM; Kim DH
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin administration during pregnancy - current insight.
    Skibinska M; Zurawska-Klis M; Krekora M; Cypryk K
    Ginekol Pol; 2021; 92(1):46-50. PubMed ID: 33576490
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease.
    Reifsnider OS; Kansal AR; Gandhi PK; Cragin L; Brand SB; Pfarr E; Fahrbach K; Ustyugova A
    BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33941549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter?
    Cavallari I; Maddaloni E; Grigioni F
    Eur J Prev Cardiol; 2021 Dec; 28(15):1670-1672. PubMed ID: 33624108
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 study.
    Araki E; Mathieu C; Shiraiwa T; Maeda H; Ikeda H; Thoren F; Arya N; Asano M; Iqbal N
    Diabetes Obes Metab; 2021 Jul; 23(7):1496-1504. PubMed ID: 33620762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years.
    Lee HW; Lee JS; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Diabetes Complications; 2021 Jan; 35(1):107747. PubMed ID: 33616043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin turns 62 in pharmacotherapy: Emergence of non-glycaemic effects and potential novel therapeutic applications.
    Mbara KC; Mofo Mato PE; Driver C; Nzuza S; Mkhombo NT; Gcwensa SK; Mcobothi EN; Owira PM
    Eur J Pharmacol; 2021 May; 898():173934. PubMed ID: 33609563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Metformin for Obesity: A Systematic Review.
    Masarwa R; Brunetti VC; Aloe S; Henderson M; Platt RW; Filion KB
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33608415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of metformin and development of dry age-related macular degeneration in a U.S. insurance claims database.
    Eton EA; Wubben TJ; Besirli CG; Hua P; McGeehan B; VanderBeek BL
    Eur J Ophthalmol; 2022 Jan; 32(1):417-423. PubMed ID: 33607930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends and associated maternal characteristics of antidiabetic medication use among pregnant women in South Korea.
    Noh Y; Choe SA; Shin JY
    Sci Rep; 2021 Feb; 11(1):4159. PubMed ID: 33603191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis.
    Guo L; Chang B; Chen L; Yang L; Liu Y; Feng B; He Q
    Sci Rep; 2021 Feb; 11(1):4131. PubMed ID: 33602996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.